MSI-78 topical anti-infective: Began Phase III trial

Magainin Pharmaceuticals Inc. (MAGN),

Read the full 49 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE